[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Medacta USA\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100494721",false,"NCT05721859","M-Vizion™ Macroscopic Radiographic Study","Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study","Inclusion Criteria:\n\n* Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).\n* Ability to understand and provide written authorization for use and disclosure of personal health information.\n* Subjects who are able and willing to comply with the study protocol and follow-up visits.\n* Patients requiring a revision total hip replacement.\n* Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.\n* Male and female patients ages 21 - 80 years of age at the time of surgery.\n\nExclusion Criteria:\n\n* Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.\n* Patients with a systemic or metabolic disorder leading to progressive bone deterioration.\n* Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and\u002For fixation to the prosthesis.\n* Patients with an active or suspected latent infection in or about the hip joint.\n* Patients that are incarcerated.","ALL","21 Years","80 Years",{"count":19,"type":20},70,"ESTIMATED","OBSERVATIONAL","Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.",[24],"Revision Hip Arthroplasty",[26,27,28],"revision","hip","arthroplasty","RECRUITING","2025-05-05",{"date":32,"type":33},"2025-05-08","ACTUAL",{"date":35,"type":33},"2022-10-12",{"date":37,"type":20},"2026-06-01",{"name":39,"class":40},"Medacta USA","INDUSTRY",7,""]